Massachusetts H1197 aims to ensure rapid whole genome sequencing for Medicaid beneficiaries with complex or acute illnesses of unknown etiology.

Massachusetts H1197 mandates the Executive Office of Health and Human Services, in collaboration with the Office of MassHealth, to provide rapid whole genome sequencing for Medicaid beneficiaries. This sequencing aims to assist healthcare professionals in diagnosing and treating patients with complex or acute illnesses of unknown etiology. The bill outlines specific conditions under which rapid whole genome sequencing is necessary, including congenital anomalies, refractory seizures, and abnormal diagnostic imaging studies.

Massachusetts H1197 aims to ensure rapid whole genome sequencing for Medicaid beneficiaries with complex or acute illnesses of unknown etiology.

Massachusetts H1197 mandates the Executive Office of Health and Human Services, in collaboration with the Office of MassHealth, to provide rapid whole genome sequencing for Medicaid beneficiaries. This sequencing aims to assist healthcare professionals in diagnosing and treating patients with complex or acute illnesses of unknown etiology. The bill outlines specific conditions under which rapid whole genome sequencing is necessary, including congenital anomalies, refractory seizures, and abnormal diagnostic imaging studies.